Options Trading Volume Surges for CAVA, URGN, and CIVI

Today’s options trading highlights noteworthy activity among several components of the Russell 3000 index, particularly for CAVA Group Inc (Symbol: CAVA). A total of 86,622 contracts have been traded, equivalent to approximately 8.7 million underlying shares, given that one contract corresponds to 100 shares. This volume represents 331.3% of CAVA’s average daily trading volume for the past month, which stands at 2.6 million shares. The $75 strike put option expiring on July 18, 2025, accounted for a significant portion of this activity, with 5,513 contracts traded, representing around 551,300 underlying shares.

Below is a chart showcasing CAVA’s trailing twelve-month trading history, with the $75 strike highlighted in orange:

UroGen Pharma Limited (URGN) Trading Highlights

UroGen Pharma Ltd (Symbol: URGN) reported options trading volume of 16,272 contracts today, reflecting approximately 1.6 million underlying shares. This volume is about 212.5% of URGN’s average daily trading volume over the past month, which is 765,575 shares. Notably, the $10 strike call option set to expire on June 20, 2025, saw 6,894 contracts traded, equating to roughly 689,400 underlying shares.

Below is a chart showing URGN’s trailing twelve-month trading history, with the $10 strike highlighted in orange:

Civitas Resources Inc (CIVI) Options Activity

Civitas Resources Inc (Symbol: CIVI) also experienced significant options trading, with 27,966 contracts changing hands. This represents approximately 2.8 million underlying shares and is about 149.8% of CIVI’s average daily trading volume, which is 1.9 million shares. The $30 strike call option expiring on May 16, 2025, had particularly high interest, with 8,670 contracts traded, corresponding to roughly 867,000 underlying shares.

Below is a chart illustrating CIVI’s trailing twelve-month trading history, with the $30 strike highlighted in orange:

For details on the available expirations for options on CAVA, URGN, or CIVI, please refer to stockoptionschannel.com.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.